Cohort Company News - MedTech Innovator

Subtle Medical Raises $12.2 Million in Series A Funding to Expand Its AI Imaging Solutions

DateNov 19 2020

Subtle will use the funds to grow their product portfolio and support the global demand to make medical imaging faster and safer for all.

Medable raises $91M for Its Clinical Trial Management Software

DateNov 19 2020

The clinical trial management software developer Medable has raised $91 million in a new round of financing as life sciences companies struggle with how to conduct the necessary validation studies of new drugs and devices in a pandemically challenged environment.

Allotrope Medical Announces FDA Clearance of StimSite™

DateNov 17 2020

StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation.

X-COR Therapeutics, an Alira Health Ventures Portfolio Company, Closes Initial $2.6M Funding Round.

DateNov 12 2020

Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.

CoapTech Awarded $1.6M from NIH for Pediatric Feeding Tube Placement Device

DateNov 12 2020

Grant will support development and clinical evaluation of world’s first ultrasound-based gastrostomy device for pediatric patients.

Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform

DateNov 11 2020

Nanowear www.nanowearinc.com, the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based diagnostic platform, SimpleSENSE.

UCSF Rosenman Institute Announces Companies Chosen for “ADAPT” Program (featuring Vynca)

DateNov 10 2020

The UCSF Rosenman Institute announced today the startups selected in “UCSF Rosenman ADAPT,” a competitive global program for startup companies developing solutions to increase healthcare efficiency. Bold, ConsejoSano, EMME, GroupWell, Oshi, Vynca, and Woebot were selected for their innovative approaches and market promise.

SepTec Is One of the 6 Winners of the Eit Health UK-Ireland #Headstart €10,000 Top up Pitch

DateNov 06 2020

SepTec Ltd Is immensely proud to be one of the 6 winners of the EIT HEALTH UK-IRELAND #Headstart €10,000 top up pitch!

Avisi Technologies: $1M NSF Grant

DateNov 03 2020

The funding will help prepare the team for clinical trials, which they plan to begin in 2021.

PercuSense Announces Project with the University of Melbourne funded by The Helmsley Charitable Trust to Develop a Single Sensor Continuous Glucose and Ketone Monitor

DateNov 02 2020

PercuSense, an intelligent biosensor and digital health company, announced it has been awarded a $2.5 million program-related investment in the form of a loan from The Leona M. and Harry B. Helmsley Charitable Trust. PercuSense will use the funding to continue development on its novel continuous monitoring system that measures both glucose and ketones on a single minimally invasive probe.

Robotic Catheterization for Mitral Valve Repair: Interview with Mark Barrish, CEO of Moray Medical

DateOct 28 2020

Moray Medical, a company based in Mountain View, California, has developed a robotic catheter and associated technology, including augmented reality and a 3D digital interface, designed to make the job easier. In fact, the company claims that using its technology to deliver cardiac therapies can be as simple as moving a cursor on a computer screen.

Venari Medical Secures $5.3M Investment to Advance the Minimally Invasive Treatment of Chronic Venous Disease

DateOct 28 2020

Venari Medical, an innovative medical device company based in Galway (Ireland), recently raised $5.3 million (€4.5 million) in seed equity funding to accelerate the development of its ground-breaking BioVena™ device for the treatment of chronic venous disease.

Sidekick Health Scores $20M for Its Gamified Digital Care Platform

DateOct 28 2020

Nordic digital therapeutics company, Sidekick Health, has closed a $20 million Series A led by pan-European VC Wellington Partners and healthcare focused VC Asabys Partners.

FineHeart Achieves Milestone For Its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study

DateOct 27 2020

FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of patients suffering from severe heart failure has announced the successful completion of a 30-day preclinical study.

Lief Selected as the Winner of the Lyfebulb-Orexo Us Innovation Award in Substance Use Disorder

DateOct 15 2020

Lief to be selected as the winner of the Lyfebulb-Orexo US, Inc. Innovation Award in Substance Use disorder.

Avenda Health Won 1st Place at Focal Therapy Gauntlet and Was Selected as the “Most Promising Ablative Technology.”

DateOct 15 2020

We competed in the Focal Therapy Gauntlet (https://lnkd.in/gPjzZXY) with 9 other cutting edge treatments for #prostate cancer at FOCAL 2020. Avenda Health won 1st place and was selected as the "Most Promising Ablative Technology."

FlowSense Monitors Hydrocephalus Shunts: Exclusive with Anna Lisa Somera, CEO of Rhaeos

DateOct 13 2020

Rhaeos, a company based in Illinois, is trying to bring to market its FlowSense device, a wearable non-invasive patch that looks like a bandage and which can provide data on flow through a shunt.

Admetsys Secures CE Mark Approval For PrecisionOne™ Automated Glycemic Control And Continuous Diagnostics System

DateOct 13 2020

The PrecisionOne system functions as a metabolic autopilot, providing automated glucose regulation and real-time analysis of blood chemistry values for critical care patients.

Navi Medical Technologies, Awarded an NHMRC Development Grant Worth Almost $900,000

DateOct 09 2020

Congratulations to Navi Medical Technologies, awarded an NHMRC Development Grant worth almost $900,000. The NHMRC’s Development Grant scheme helps take research to the proof-of-concept stage, a critical step on the pathway to successful commercialisation.

Interventional Radiologists Report 100% Clinical Success Using Absorbable IVC Filters in First Human Study (featuring Adient Medical)

DateOct 01 2020

Implanting absorbable vena cava filters in patients with increased risk of pulmonary embolism resulted in a 100% clinical success rate, according to the results of a first in-human study published Tuesday.